News from indivior plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 26, 2019, 15:19 ET Announcement of National Institutes of Health (NIH) Grant Award through the NIH Helping to End Addiction Long-term (HEAL) Initiative

Indivior PLC (LON: INDV) announces that the National Institutes of Health (NIH) has granted Indivior's application entitled "Clinical Evaluation of...


Jul 11, 2019, 05:15 ET Indivior Raises FY 2019 Net Revenue and Net Income Guidance; Cash at H1 2019 Expected to be Approximately $985m

Indivior PLC (LON: INDV) today announced revised expectations for FY 2019 net revenue and net income following stronger than expected H1 2019 net...


May 02, 2019, 07:15 ET Indivior First Quarter 2019 Results Now Available; Conference Call With Leadership Today

Indivior PLC (LON: INDV) today announced that its first quarter 2019 press release and investor supplement are now available via the London Stock...


Apr 09, 2019, 18:01 ET Statement of Indivior on Grand Jury Indictment

Indivior PLC (LON: INDV) issued the following statement today in response to an indictment returned by a federal grand jury in the Western District...


Feb 27, 2019, 08:06 ET Indivior Announces Launch of PERSERIS™ (risperidone) for the Treatment of Schizophrenia in Adults

Indivior PLC (LON: INDV) today announced the launch of once-monthly PERSERIS™ (risperidone) for extended-release injectable suspension in the United...


Feb 20, 2019, 09:37 ET Indivior Announces Launch of SUBOXONE® (buprenorphine and naloxone) Sublingual Film Authorized Generic

Indivior PLC (LON: INDV) today announced that its U.S. affiliate, Indivior Inc., has launched an authorized generic version of SUBOXONE®...


Dec 18, 2018, 07:20 ET Indivior Provides Legal and Trading Update; Confirms Launch of PERSERIS™ and Key Elements of Contingency Plan

Indivior PLC (the "Company") with today's announcement and accompanying supplement published on its website (http://www.indivior.com) is: Providing...


Dec 12, 2018, 08:00 ET Court of Appeals for the Federal Circuit Declines to Immediately Issue Mandate After Preliminary Injunction Ruling

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied Dr....


Nov 27, 2018, 08:00 ET Indivior to Host Conference Call on December 18th; Previously-Scheduled Capital Markets Day to be Held in February 2019

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that in light of the recent decision by the Court of Appeals for the Federal...


Nov 23, 2018, 09:56 ET Indivior Announces Health Canada Approval of SUBLOCADE™ (Buprenorphine Extended-Release) Injection for Patients with Moderate to Severe Opioid Use Disorder

Indivior PLC (LON: INDV) today announced that Health Canada has approved SUBLOCADETM (buprenorphine extended-release) injection for subcutaneous...


Nov 21, 2018, 09:30 ET Court of Appeals for the Federal Circuit Lifts Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated the...


Nov 19, 2018, 08:39 ET PERSERIS™, the First Once-Monthly Risperidone-Containing Subcutaneous Long-Acting Injectable, Now Available in the U.S. for the Treatment of Schizophrenia in Adults

Indivior PLC (LON: INDV) today announced that PERSERIS™ (risperidone) for extended-release injectable suspension is now available in the United...


Nov 06, 2018, 08:00 ET Indivior Announces Upcoming Investor Events

Indivior PLC (LON: INDV) today announced the following upcoming investor events: Stifel 2018 Healthcare Conference, New York City: On Tuesday,...


Nov 01, 2018, 07:26 ET Indivior Announces Nine Month and Third Quarter 2018 Results

Indivior PLC (LON: INDV) today announced that its financial results for the period ended September 30, 2018, including the earnings release and...


Sep 26, 2018, 11:57 ET Indivior Provides Update on Key Business Drivers and Expectations

Indivior PLC (LON: INDV) today is providing a further update on key business drivers and expectations related to: FY 2018 net revenue and net income...


Sep 12, 2018, 06:51 ET Indivior Unable to Participate in Morgan Stanley Healthcare Conference Due to Adverse Weather

Indivior PLC (LON: INDV) today announced that due to adverse weather expected from Hurricane Florence, the recently declared state of emergency in...


Sep 10, 2018, 08:00 ET Indivior Prepays $150 Million of Outstanding Debt

Indivior PLC (LON: INDV) today announced that it has completed the prepayment of $150 million of its outstanding Term loan facilities. As a result,...


Jul 31, 2018, 08:03 ET Indivior Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film Upheld

Indivior PLC (LON: INDV) (Indivior or the Company) today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied Dr....


Jul 25, 2018, 02:45 ET Indivior Announces H1 2018 Results

Period to June 30th Q2 2018 $m Q2 2017 $m % ∆ Actual FX % ∆ Constant FX H1 2018 $m H1 2017 $m % ∆ Actual FX % ∆ Constant FX Net Revenue 268 288 -7 -8 ...


Jul 13, 2018, 18:22 ET Indivior Is Granted Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted a...


Jul 11, 2018, 07:47 ET Indivior Sees FY 2018 Net Revenue and Adjusted Net Income Below Previous Expectations

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that its previous FY 2018 financial guidance (net revenue: $1,130m - $1,170m;...


Jul 10, 2018, 09:00 ET Indivior to Announce and Present Half Year 2018 Results on July 25th

Indivior PLC (LON: INDV) today announced that it will release its half year 2018 results on July 25th at 7:00 a.m. London time (2:00 a.m. U.S. EDT)....


Jun 28, 2018, 06:07 ET Indivior's Temporary Restraining Order is Extended

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey heard Indivior's...


Jun 15, 2018, 10:11 ET Indivior Responds to Generic SUBOXONE® Approvals and Dr. Reddy's Launch "At-Risk"

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that it is aware that, on 14 June 2018, the US FDA approved generic versions...


Jun 15, 2018, 08:00 ET Indivior Is Granted Temporary Restraining Order

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted...